Oxford Cancer Analytics

oxcan.org

Oxford Cancer Analytics (OXcan) is transforming cancer treatment through its innovative DEcancer platform, which utilizes machine learning for early cancer detection via minimally invasive blood tests. The company focuses on lung cancer, aiming to expedite product deployment in this strategic market. With a multidisciplinary team and international partnerships, OXcan is positioned to maximize detection accuracy and improve cancer management, offering hope to patients and families worldwide. Their recent funding round of $3.7M led by Eka Ventures highlights their traction and commitment to revolutionizing liquid biopsy technology.